Sort
141,003 grants matching “cytokine”
Cell Based Immunomodulation to Promote Post-Infarct Myocardial Repair
$707,516Ravi K Ghanta · Baylor College Of Medicine · R01 · FY2023 · HL
Antenatal Anxiety and Dyadic Immune Risk(ADIR Study)
$707,499Lauren M Osborne · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · HD
Characterizing Mucosal Changes in the FRT Leading to Increased HIV Acquisition
$707,472Thomas Hope · Northwestern University At Chicago · R01 · FY2019 · AI
Research Support Core C: Computational Biology in Substance Use
$707,445Mark R Chance · Case Western Reserve University · P30 · FY2021 · DA
STICH Trial-Coordinating Center
$707,433Robert H Jones · Duke University · U01 · FY2010 · HL
Glia maturation factor-gamma modulation of signaling pathways in macrophages
$707,429Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
T Regulatory Lymphocytes, HDL Function, and Atherosclerosis
$707,427Catherine C Hedrick · La Jolla Institute For Immunology · R01 · FY2013 · HL
programmed cell death in regulation of autoimmunity
$707,372Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · Z01 · FY2008 · AR
TL1A and its receptor DR3 in normal and autoimmune T cell responses
$707,372Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · Z01 · FY2008 · AR
The Neurobiology Of Major Depression
$707,342Philip W Gold · National Institute Of Mental Health · Z01 · FY2007 · MH
Regulation of the biosynthesis of a novel class of anti-diabetic lipids
$707,327Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2019 · DK
Regulation of the biosynthesis of a novel class of anti-diabetic lipids
$707,327Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2017 · DK
Regulation of the biosynthesis of a novel class of anti-diabetic lipids
$707,327Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2018 · DK
Regulation of the biosynthesis of a novel class of anti-diabetic lipids
$707,327Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2020 · DK
Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison
$707,291Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Stress Exposure and Immune Outcomes in Children
$707,262Thomas G O'Connor · University Of Rochester · R01 · FY2016 · MH
Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma
$707,188William Gerald Teague · University Of Virginia · R01 · FY2023 · AI
Impact of Cellular and Extracellular Host Components on Tumor Progression
$707,171Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2014 · CA
Bromine Inhalation Induced Lung Injury: Novel Mechanisms and Treatment Strategies
$707,129Sadis Matalon · University Of Alabama At Birmingham · U01 · FY2019 · ES
Alveolar macrophage subset ontogeny and differentiation during ARDS
$707,105Eric Douglas Morrell · University Of Washington · R01 · FY2025 · HL
Novel Cellular Therapies for Ph+ leukemia
$707,089Richard A. Van Etten · Tufts Medical Center · R01 · FY2009 · HL
Effect of randomized cocoa supplementation on inflammaging and epigenetic aging
$707,030Yanbin Dong · Augusta University · R01 · FY2024 · HL
Cardiopulmonary Risk Assessment from Smoke Exposure at the Wildland Urban Interface
$706,984Jessica M Oakes · Northeastern University · R01 · FY2022 · ES
Targeting 5' leader-encoded defective ribosomal products for HIV T cell vaccines
$706,916George M Shaw · University Of Pennsylvania · R01 · FY2019 · AI
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
$706,804Larry S. Schlesinger · Texas Biomedical Research Institute · R01 · FY2020 · AI